Magnetar Financial’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Magnetar Financial’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-923,581	Closed	-$69.5K	–	2016
2022 Q2	$69.5K	Buy	+923,581	New	+$41M	0.72%	27
2021 Q3	–	Sell	-6,059	Closed	-$473	–	1603
2021 Q2	$473	Buy	+6,059	New	+$448K	﹤0.01%	905

Magnetar Financial's TPTX Position: Q3 2022 in Review

Magnetar Financial sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 923,581 shares — an estimated $69.5K sold.

Magnetar Financial first reported a position in TPTX in Q2 2021 and held it in 2 quarters. The position peaked at $69.5K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Magnetar Financial reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Magnetar Financial sold 923,581 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $69.5K.
Magnetar Financial first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
Magnetar Financial's Turning Point Therapeutics, Inc. Common Stock position peaked at $69.5K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.